Stock A214450 PHARMARESEARCH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company PharmaResearch Co., Ltd.

Equities

A214450

KR7214450009

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-07 EDT 		5-day change 1st Jan Change
135,800 KRW +0.67% Intraday chart for PharmaResearch Co., Ltd. +6.43% +24.02%
2023 PharmaResearch Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2021 PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd. CI

Business Summary

PharmaResearch Co Ltd, formerly Pharma Research Products Co Ltd, is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The Company mainly provides its products in domestic market.

Number of employees: 354

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceuticals, Quasi-drugs, Cosmetics, Medical Devices and Other Chemical Products
100.0 %
194,759 100.0 % 261,011 100.0 % +34.02%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
65.2 %
138,654 71.2 % 170,073 65.2 % +22.66%
Overseas
34.8 %
56,104 28.8 % 90,938 34.8 % +62.09%

Managers

Managers TitleAgeSince
Ki-Seok Kang CEO
 Chief Executive Officer 48 00-01-31
Shin-Kyou Kim CEO
 Chief Executive Officer 59 -
Sang-Soo Jung CHM
 Chairman 66 -

Members of the board

Members of the board TitleAgeSince
Shin-Kyou Kim CEO
 Chief Executive Officer 59 -
Sang-Soo Jung CHM
 Chairman 66 -
Ki-Seok Kang CEO
 Chief Executive Officer 48 00-01-31
Seung-Geol Baek BRD
 Director/Board Member 54 -
Sang-Won Lee BRD
 Director/Board Member 54 19-03-26
Ha-Seok Bae BRD
 Director/Board Member 58 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,359,054 6,220,287 ( 60.05 %) 119,952 ( 1.158 %) 60.05 %

Shareholders

NameEquities%Valuation
Sang-Soo Jung
34.51 %
3,561,663 34.51 % 267 M ₩
National Pension Service of Korea
7.278 %
751,108 7.278 % 56 M ₩
VIP Research & Management Inc.
4.802 %
495,563 4.802 % 37 M ₩
Ki-Seok Kang
3.727 %
384,617 3.727 % 29 M ₩
PHARMARESEARCH CO., LTD.
1.162 %
119,952 1.162 % 9 M ₩
Seung-Geol Baek
0.3391 %
35,000 0.3391 % 3 M ₩
Phillip Capital Management (S) Ltd.
0.1163 %
12,000 0.1163 % 899 387 ₩
Yu-jin Jung
0.0976 %
10,071 0.0976 % 754 811 ₩
Rae-seung Jung
0.0969 %
10,000 0.0969 % 749 489 ₩
Pil-hyun Park
0.0969 %
10,000 0.0969 % 749 489 ₩

Holdings

NameEquities%Valuation
PHARMARESEARCH BIO CO., LTD.
47.28%
 1,921,628 47.28% 45,676,579 $
PHARMARESEARCH CO., LTD.
1.16%
 119,952 1.16% 8,990,274 $

Company contact information

PharmaResearch Co., Ltd.

77-19 Gwahakdanji-ro Bundang-gu

25452, Gangneung-si

+82 33 645 7640

http://www.pr-products.co.kr
address PharmaResearch Co., Ltd.(A214450)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Ratings for PharmaResearch Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
135,800 KRW
Average target price
175,000 KRW
Spread / Average Target
+28.87%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
PHARMARESEARCH CO., LTD. Stock PharmaResearch Co., Ltd.
+24.02% 1.02B
CSL LIMITED Stock CSL Limited
-2.35% 89.33B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+4.08% 41.19B
BIOGEN INC. Stock Biogen Inc.
-15.09% 31.87B
UCB Stock UCB
+53.68% 24.52B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-15.13% 15.68B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-8.63% 12.34B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-40.39% 12.23B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.22% 8.83B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.43% 8.28B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A214450 Stock
  4. Company PharmaResearch Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW